Pacific Biosciences of California Inc. (Nasdaq: PACB) widened first quarter losses more than expected sending the stock price down $1.12 to close at $4.05.
Pacific Biosciences widens losses
April 27, 2017 at 16:58 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|